foscarbidopaParkinson’s diseasePwP
…blets or continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDp/CDp) for 12 weeks.Methods This post hoc analysis evaluated…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: foscarbidopa ×
foscarbidopa
This drug is selected. Its supporting articles are shown below.